--- title: "YONGAN PHARMACEUTICAL: Net profit for the third quarter was 13.0005 million yuan, a year-on-year increase of 38.75%" type: "News" locale: "en" url: "https://longbridge.com/en/news/263232508.md" description: "YONGAN PHARMACEUTICAL announced that its revenue for the third quarter was 210 million yuan, an increase of 8.75% year-on-year; net profit was 13.0005 million yuan, an increase of 38.75% year-on-year. Revenue for the first three quarters was 577 million yuan, a decrease of 6.72% year-on-year; net profit was 25.4963 million yuan, a decrease of 58.78% year-on-year" datetime: "2025-10-29T07:54:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263232508.md) - [en](https://longbridge.com/en/news/263232508.md) - [zh-HK](https://longbridge.com/zh-HK/news/263232508.md) --- # YONGAN PHARMACEUTICAL: Net profit for the third quarter was 13.0005 million yuan, a year-on-year increase of 38.75% YONGAN PHARMACEUTICAL announced that its revenue for the third quarter was 210 million yuan, an increase of 8.75% year-on-year; net profit was 13.0005 million yuan, an increase of 38.75% year-on-year. Revenue for the first three quarters was 577 million yuan, a decrease of 6.72% year-on-year; net profit was 25.4963 million yuan, a decrease of 58.78% year-on-year ### Related Stocks - [002365.CN](https://longbridge.com/en/quote/002365.CN.md) ## Related News & Research - [A historically strong stretch for the U.S. stock market is about to begin](https://longbridge.com/en/news/295557041.md) - [XCMG's Electric Mining Push Featured in The Australian Financial Review](https://longbridge.com/en/news/295381066.md) - [ADNOCGAS: H1 2026 saw lower revenue and profit, major asset write-offs, and persistent geopolitical risks](https://longbridge.com/en/news/295360826.md) - [Yonghe Medical schedules board meeting to review interim results, consider dividend](https://longbridge.com/en/news/295377904.md) - [How A Fake IRGC Quote On Nuclear Weapons Reached Netanyahu's Speech](https://longbridge.com/en/news/295479236.md)